Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant ...
US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...
HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension, was one of nine studies selected as most impactful ...
The sun rises over lush farm fields of on the outskirts of Lagos. For more than 20 years, a farmer named Joe has tilled the land, coaxing life from the earth and reaping bountiful harvests. But here, ...
The trial results support Tukysa-Herceptin-Perjeta as yet another option for breast cancer patients in the frontline ...
Cosmetic ingredients, particularly pigments, preservatives, and petroleum derivatives, are raising concerns about long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback